Patents-Review.com
ClassID:

116516 ⎘

C12Y302/01018 - CPC Classification

Classification description:

Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2); Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1) Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase

Recent Application in this class:
#1
20260110695
2026-04-23

Methods for Standardizing Lectin Reagents, IgA1 Calibration Standards, and Quantitative Measurement of Galactose-Deficient IgA1 in Human Samples

 #2
20260092921
2026-04-02

MUTATED NEUROAMINIDASE

 #3
20260092290
2026-04-02

RECOMBINANT VIRAL VECTOR, RECOMBINANT ADENO-ASSOCIATED VIRUS COMPRISING THE SAME, AND USES THEREOF IN TREATING SIALIDOSIS

 #4
20260062726
2026-03-05

HYBRID METHOD FOR PRODUCING COMPLEX HMOS

 #5
20260061045
2026-03-05

METHOD FOR PREVENTION AND TREATMENT OF VIRAL DISEASE

 #6
20260041751
2026-02-12

FUSION PROTEIN AND VACCINE

 #7
20260021175
2026-01-22

IMMUNOGENIC COMPOSITIONS AND USES THEREOF

 #8
20250387457
2025-12-25

Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients

 #9
20250354133
2025-11-20

SIALIDASE FUSION MOLECULES AND RELATED USES

 #10
20250288662
2025-09-18

MULTIVALENT DISPLAY ON ENVELOPED PARTICLES WITH HUMAN OLIGOMERIZATION DOMAINS

 #11
20250257345
2025-08-14

DAS181 VARIANT COMPOSITIONS

 #12
20250255953
2025-08-14

RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED HA FOR REPLICATION IN EGGS

 #13
20250135033
2025-05-01

COMPOSITIONS AND METHODS FOR TREATING SIALIDOSIS

 #14
20250051397
2025-02-13

VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER

 #15
20250049846
2025-02-13

METHODS AND COMPOSITIONS FOR TREATING CANCER WITH IMMUNE CELLS

 #16
20240417708
2024-12-19

TAGGED EXOGLYCOSIDASE ENZYMES AND IMMOBILIZED GLYCAN SEQUENCING APPROACH

 #17
20240392041
2024-11-28

Site-Specific Crosslinking of Antibodies

 #18
20240368546
2024-11-07

Engineered Expression of Cell Surface and Secreted Sialidase by CAR T Cells for Increased Efficacy in Solid Tumors

 #19
20240335525
2024-10-10

TRUNCATED INFLUENZA NEURAMINIDASE AND METHODS OF USING THE SAME

 #20
20240299582
2024-09-12

VIRAL DELIVERY OF A SIALIDASE TO TREAT CANCER

 #21
20240287488
2024-08-29

NOVEL SIALIDASES AND USES THEREOF

 #22
20240287175
2024-08-29

COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED DISEASES

 #23
20240285757
2024-08-29

COMPOSITIONS AND METHODS FOR ENHANCING CAR T CELL EFFICACY THROUGH THE ENGINEERED SECRETION OF C. PERFRINGENS NEURAMINIDASE

 #24
20240279328
2024-08-22

METHODS TO GLYCOENGINEER PROTEINS

 #25
20240207391
2024-06-27

ENGINEERED INFLUENZA VIRUSES EXPRESSING SARS-COV-2 ANTIGENS, VACCINES AND METHODS OF MAKING AND USING THE SAME

 #26
20240197921
2024-06-20

SIGNAL PEPTIDES

 #27
20240181051
2024-06-06

SIALYDASE LINKED HIV ANTIBODIES AND METHODS OF USE

 #28
20240151727
2024-05-09

DIAGNOSTIC ALGORITHMS FOR DETERMINING AND TREATING CLINICALLY SIGNIFICANT PROSTATE CANCER BASED ON SIALYLATED AND FUCOSYLATED PROSTATE SPECIFIC ANTIGEN

 #29
20240091341
2024-03-21

FUSION PROTEIN AND VACCINE

 #30
20240082327
2024-03-14

RETROVIRAL VECTORS

 #31
20240067729
2024-02-29

ANTI-PD-L1 ANTIBODIES AND FUSION PROTEINS THEREOF

 #32
20240059792
2024-02-22

SIALIDASE-HER2-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

 #33
20240059773
2024-02-22

SIALIDASE-PD-1-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

 #34
20230332174
2023-10-19

NUCLEIC ACID CONSTRUCT, RECOMBINANT INFLUENZA VIRUS, METHOD FOR PREPARING A RECOMBINANT INFLUENZA VIRUS, COMPOSITION AND USE

 #35
20230293711
2023-09-21

DISRUPTION OF CD28-SIALOSIDE LIGAND COMPLEXES TO ENHANCE T CELL ACTIVATION

 #36
20230287140
2023-09-14

Conjugates for Targeted Cell Surface Editing

 #37
20230285537
2023-09-14

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

 #38
20230279464
2023-09-07

BIOSENSORS FOR SELECTIVELY IDENTIFYING AZIDE IONS

 #39
20230265406
2023-08-24

RECOMBINANT SIALIDASES WITH REDUCED PROTEASE SENSITIVITY, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME

 #40
20230149487
2023-05-18

DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR MICROENVIRONMENT

 #41
20230097374
2023-03-30

Recombinant expression platform, constructs and methods for expression of Difficult to Express Proteins (DTE-Ps)

 #42
20230090779
2023-03-23

ENGINEERED INFLUENZA NEURAMINIDASE ANTIGENS

 #43
20220406435
2022-12-22

METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)

 #44
20220403358
2022-12-22

RECOMBINANT NEURAMINIDASE AND USES THEREOF

 #45
20220387616
2022-12-08

SIALIDASE-HER2-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

 #46
20220380742
2022-12-01

SIALIDASE-CD20-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

 #47
20220372458
2022-11-24

SIALIDASE-PD-L1-ANTIBODY FUSION PROTEINS AND METHODS OF USE THEREOF

 #48
20220370527
2022-11-24

DELIVERY OF SIALIDASE TO CANCER CELLS, IMMUNE CELLS AND THE TUMOR MICROENVIRONMENT

 #49
20220362351
2022-11-17

RECOMBINANT SIALIDASES AND METHODS OF USING THE SAME

 #50
20220356457
2022-11-10

RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME

 #51
20220249652
2022-08-11

INFLUENZA VIRUS NEURAMINIDASE AND USES THEREOF

 #52
20220242918
2022-08-04

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #53
20220233657
2022-07-28

TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS

 #54
20220226507
2022-07-21

OPTIMIZED GENE THERAPY TARGETING RETINAL CELLS

 #55
20220226357
2022-07-21

METHODS FOR TREATING NEURODEGENERATIVE DISORDERS

 #56
20220202927
2022-06-30

Recombinant influenza viruses with stabilized HA for replication in eggs

 #57
20220105179
2022-04-07

GLYCOENGINEERING IMMUNOGLOBULIN E

 #58
20220041997
2022-02-10

Method for rescuing influenza virus and composition therefor

 #59
20210353719
2021-11-18

Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture

 #60
20210330758
2021-10-28

TREATMENT FOR BK POLYOMAVIRUS INFECTION

 #61
20210221851
2021-07-22

VSV/NDV HYBRID VIRUSES FOR ONCOLYTIC THERAPY OF CANCER

 #62
20210148912
2021-05-20

BIOMARKER FOR DETECTING CANCER

 #63
20210108190
2021-04-15

METHODS AND COMPOSITIONS FOR PRODUCING DOUBLE ALLELE KNOCK OUTS

 #64
20210062171
2021-03-04

NOVEL SIALIDASES AND USES THEREOF

 #65
20210052708
2021-02-25

Treatment of infection by human enterovirus D68

 #66
20210046176
2021-02-18

METHODS OF GENERATING BROADLY PROTECTIVE VACCINE COMPOSITIONS COMPRISING NEURAMINIDASE

 #67
20210046165
2021-02-18

Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients

 #68
20200390868
2020-12-17

ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYE

 #69
20200370013
2020-11-26

Engineered Expression of Cell Surface and Secreted Sialidase by CAR T Cells for Increased Efficacy in Solid Tumors

 #70
20200330584
2020-10-22

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

 #71
20200317778
2020-10-08

Compositions and methods for treating age-related diseases

 #72
20200297822
2020-09-24

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

 #73
20200281954
2020-09-10

Mixtures of human milk oligosaccharides comprising 3′-O-sialyllactose

 #74
20200268873
2020-08-27

Polygene influenza vaccine

 #75
20200261557
2020-08-20

GLYCOSIDASE REGIMEN FOR TREATMENT OF INFECTIOUS DISEASE

 #76
20200261552
2020-08-20

Method of preventing aggravation of a disease involving a biological mechanism controlled by a dendritic cell immunoreceptor

 #77
20200237898
2020-07-30

VACCINES INTELLIGENTLY PRODUCED BY EPITOPE RECOMBINATION (VIPER) FOR INFLUENZA

 #78
20200223892
2020-07-16

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #79
20200197310
2020-06-25

Technology for Preparation of Macromolecular Microspheres

 #80
20200164049
2020-05-28

TREATMENT OF HUMAN METAPNEUMOVIRUS

 #81
20200164048
2020-05-28

Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture

 #82
20200103364
2020-04-02

Electrochemical methods and compounds for the detection of enzymes

 #83
20200087704
2020-03-19

METHODS OF TREATING DEMENTIA ASSOCIATED WITH ALZHEIMER'S DISEASE WITH PROTECTIVE PROTEIN/CATHEPSIN A (PPCA)

 #84
20200016244
2020-01-16

TREATMENT FOR BK POLYOMAVIRUS INFECTION

 #85
20200016243
2020-01-16

TREATMENT OF INFECTION BY HUMAN ENTEROVIRUS D68

 #86
20190365882
2019-12-05

Universal influenza vaccine using cold-adapted live-attenuated virus

 #87
20190328863
2019-10-31

Recombinant virus, composition comprising the same, and uses thereof

 #88
20190262446
2019-08-29

Compositions and Methods for Increasing Immunogenicity of Glycoprotein Vaccines

 #89
20190248919
2019-08-15

Conjugates for targeted cell surface editing

 #90
20190233404
2019-08-01

Compositions and methods for neuraminidase detection and quantification

 #91
20190224311
2019-07-25

Adjuvants

 #92
20190224305
2019-07-25

Engineered influenza polynucleotides, viruses, vaccines and methods of making and using the same

 #93
20190201503
2019-07-04

SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER

 #94
20190194264
2019-06-27

LIPOPROTEIN EXPORT SIGNALS AND USES THEREOF

 #95
20190177438
2019-06-13

Site-specific crosslinking of antibodies

 #96
20190167781
2019-06-06

Recombinant influenza viruses with stabilized HA for replication in eggs

 #97
20190153039
2019-05-23

VSV/NDV hybrid viruses for oncolytic therapy of cancer

 #98
20190119661
2019-04-25

Mutant sialidase having trans-sialidase activity for use in production of sialylated glycans

 #99
20190091305
2019-03-28

Glycosidase regimen for the treatment of chronic viral infection

 #100
20190062713
2019-02-28

Highly efficient influenza matrix (M1) proteins

 #101
20190060239
2019-02-28

Technology for the Preparation of Microparticles

 #102
20190048324
2019-02-14

HIGH TITER RECOMBINANT INFLUENZA VIRUSES FOR VACCINES

 #103
20190037899
2019-02-07

Intramolecular Trans-Sialidase

 #104
20190017057
2019-01-17

Live bacterial vectors for prophylaxis or treatment

 #105
20190008949
2019-01-10

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR INFLUENZA

 #106
20180334665
2018-11-22

Methods and compositions for producing double allele knock outs

 #107
20180298063
2018-10-18

Engineered influenza antigenic polypeptides and immunogenic compositions thereof

 #108
20180265910
2018-09-20

Cleavage of Fucose in N-Glycans

 #109
20180200345
2018-07-19

Process and composition for low dose insemination

 #110
20180193432
2018-07-12

ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYE

 #111
20180185462
2018-07-05

Peptides for inducing Chagas disease responses

 #112
20180177852
2018-06-28

TREATMENT OF HUMAN METAPNEUMOVIRUS

 #113
20180155761
2018-06-07

Cell-permeable probes for identification and imaging of sialidases

 #114
20180140683
2018-05-24

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

 #115
20180078574
2018-03-22

Mixtures of human milk oligosaccharides comprising 3 ′-O-sialyllactose

 #116
20180071219
2018-03-15

Technology for preparation of macromolecular microspheres

 #117
20180057854
2018-03-01

Methods of treating dementia associated with Alzheimer's disease with protective protein/cathepsin A (PPCA)

 #118
20180055917
2018-03-01

Methods of generating anti-inflammatory stem cells

 #119
20180028449
2018-02-01

Technology for the Preparation of Microparticles

 #120
20170354720
2017-12-14

Class of therapeutic protein based molecules

 #121
20170312346
2017-11-02

Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture

 #122
20170306002
2017-10-26

Potent anti-influenza A neuraminidase subtype N1 antibody

 #123
20170304428
2017-10-26

Compositions and methods for increasing immunogenicity of glycoprotein vaccines

 #124
20170290893
2017-10-12

Treatment of infection by human enterovirus D68

 #125
20170253861
2017-09-07

Highly efficient influenza matrix (M1) proteins

 #126
20170219583
2017-08-03

Method of detection of analyte active forms and determination of the ability of substances to bind into analyte active sites

 #127
20170202947
2017-07-20

Computationally optimized broadly reactive antigens for influenza

 #128
20170151315
2017-06-01

Methods, Compounds and Compositions for Treatment of Influenza and Parainfluenza Patients

 #129
20170131277
2017-05-11

Reagents and methods for detecting influenza

 #130
20170119859
2017-05-04

TREATMENT OF MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS

 #131
20170102349
2017-04-13

Electrochemical methods and compounds for the detection of enzymes

 #132
20170079920
2017-03-23

Technology for the Preparation of Microparticles

 #133
20170016899
2017-01-19

Methods of detecting influenza virus

 #134
20160324941
2016-11-10

Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture

 #135
20160304933
2016-10-20

Methods and compositions to detect the level of lysosomal exocytosis activity and methods of use

 #136
20160235675
2016-08-18

Technology for the Preparation of Microparticles

 #137
20160228518
2016-08-11

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

 #138
20160222393
2016-08-04

Live bacterial vectors for prophylaxis or treatment

 #139
20160208223
2016-07-21

High titer recombinant influenza viruses for vaccines

 #140
20160184407
2016-06-30

Class of therapeutic protein based molecules

 #141
20160166677
2016-06-16

Computationally optimized broadly reactive antigens for H1N1 influenza

 #142
20160122726
2016-05-05

Influenza virus reassortment

 #143
20160106817
2016-04-21

Treatment for BK polyomavirus infection

 #144
20160101161
2016-04-14

ANTI-VIRAL THERAPEUTIC FOR INFECTION OF THE EYE

 #145
20160100599
2016-04-14

Use of glycosidase in preparation of a milk product

 #146
20160076013
2016-03-17

Mutant sialidase having trans-sialidase activity for use in production of sialylated glycans

 #147
20160000064
2016-01-07

Platelet Storage and Reduced Bacterial Proliferation in Platelet Products Using a Sialidase Inhibitor

 #148
20150374802
2015-12-31

Compositions and methods for treating inflammatory diseases

 #149
20150352193
2015-12-10

SELECTIVE GLYCOSIDASE REGIMEN FOR IMMUNE PROGRAMMING AND TREATMENT OF CANCER

 #150
20150307849
2015-10-29

Highly efficient influenza matrix (M1) proteins

 #151
20150291946
2015-10-15

Methods and Vectors for Generating Asialylated Immunoglobulins

 #152
20150290134
2015-10-15

TECHNOLOGY FOR PREPARATION OF MACROMOLECULAR MICROSPHERES

 #153
20150225766
2015-08-13

Cell-permeable probes for identification and imaging of sialidases

 #154
20150147784
2015-05-28

Reagents and methods for detecting influenza virus proteins

 #155
20150044247
2015-02-12

Computationally optimized broadly reactive antigens for H3N2, H2N2, and B influenza viruses

 #156
20150024500
2015-01-22

Methods and compositions for producing double allele knock outs

 #157
20150017150
2015-01-15

Methods, Compounds, and Compositions For Treatment and Prophylaxis in the Respiratory Tract

 #158
20140377245
2014-12-25

METHODS AND COMPOSITIONS TO DETECT THE LEVEL OF LYSOSOMAL EXOCYTOSIS ACTIVITY AND METHODS OF USE

 #159
20140336140
2014-11-13

Methods for providing sialylated oligosaccharides

 #160
20140328820
2014-11-06

Class of therapeutic protein based molecules

 #161
20140220661
2014-08-07

Live bacterial vaccines for prophylaxis or treatment of infection

 #162
20140004138
2014-01-02

Detoxified pneumococcal neuraminidase and uses thereof

 #163
20130251848
2013-09-26

Use of glycosidase in preparation of a milk product

 #164
20130245095
2013-09-19

Treatment of sialidase 4 (NEU4) related diseases by inhibition of natural antisense transcript to NEU4

 #165
20130095528
2013-04-18

Bifidobacterial gene sequences and their use

 #166
20130039938
2013-02-14

Highly efficient influenza matrix (M1) proteins

 #167
20130034578
2013-02-07

RECOMBINANT MULTIMERIC INFLUENZA PROTEINS

 #168
20130018177
2013-01-17

Production of sialylated -glycans in lower eukaryotes

 #169
20120321722
2012-12-20

Platelet Storage and Reduced Bacterial Proliferation In Platelet Products Using A Sialidase Inhibitor

 #170
20120321601
2012-12-20

Increased In Vivo Circulation Time of Platelets After Storage With A Sialidase Inhibitor

 #171
20120301576
2012-11-29

USE OF SIALIDASE IN DAIRY TECHNOLOGY

 #172
20120276131
2012-11-01

ANTI-TRYPANOSOMIASIS VACCINES AND DIAGNOSTICS

 #173
20120201780
2012-08-09

T. CRUZI-DERIVED NEUROTROPHIC AGENTS AND METHODS OF USE THEREFOR

 #174
20120184016
2012-07-19

NOVEL PROTEIN AND GENE THAT CODES THEREFOR

 #175
20120142080
2012-06-07

Live bacterial vaccines for viral infection prophylaxis or treatment

 #176
20120141590
2012-06-07

Technology for the Preparation of Microparticles

 #177
20120141519
2012-06-07

Reagents and methods for detecting influenza virus proteins

 #178
20120135023
2012-05-31

Influenza hemagglutinin and neuraminidase variants

 #179
20120116062
2012-05-10

Technology for preparation of macromolecular microspheres

 #180
20120114627
2012-05-10

Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation

 #181
20120040474
2012-02-16

Glycan-specific analytical tools

 #182
20110262961
2011-10-27

Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation

 #183
20110195480
2011-08-11

Production of hemagglutinin-neuraminidase protein in microalgae

 #184
20110189228
2011-08-04

Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof

 #185
20110182875
2011-07-28

Class of therapeutic protein based molecules

 #186
20110171132
2011-07-14

Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract

 #187
20110104168
2011-05-05

Detoxified pneumococcal neuraminidase and uses thereof

 #188
20110091956
2011-04-21

Biomolecule-immobilized carrier and method for immobilizing biomolecule on carrier

 #189
20110070263
2011-03-24

INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS

 #190
20110027831
2011-02-03

PRODUCTION OF SIALYLATED N-GLYCANS IN LOWER EUKARYOTES

 #191
20100291624
2010-11-18

Compositions and methods for improved glycoprotein sialylation

 #192
20100285063
2010-11-11

Canine influenza virus and vaccine therefore

 #193
20100279356
2010-11-04

Production of sialylated -glycans in lower eukaryotes

 #194
20100278805
2010-11-04

Compositions for inhibiting atherosclerosis

 #195
20100226908
2010-09-09

Compositions for promoting wound healing and treating psoriasis

 #196
20100172911
2010-07-08

Methods and vectors for generating asialylated immunoglobulins

 #197
20100167344
2010-07-01

Sialidases

 #198
20100166874
2010-07-01

Technology for Preparation of Macromolecular Microspheres

 #199
20100145015
2010-06-10

Compositions and methods for increasing immunogenicity of glycoprotein vaccines

 #200
20100113383
2010-05-06

Bifidobacterial gene sequences and their use

 #201
20090263371
2009-10-22

Use polysaccharides for promotion of enzymatic activity

 #202
20090175898
2009-07-09

Influenza Hemagglutinin And Neuraminidase Variants

 #203
20090175805
2009-07-09

Neuraminidase Inhibitors and uses thereof

 #204
20090148432
2009-06-11

Compositions for inhibiting atherosclerosis

 #205
20090142327
2009-06-04

Class of therapeutic protein based molecules

 #206
20090098207
2009-04-16

Technology for the Preparation of Microparticles

 #207
20090068167
2009-03-12

Compositions for promoting wound healing and treating psoriasis

 #208
20090047286
2009-02-19

H2N3 influenza A viruses and methods of use

 #209
20080124355
2008-05-29

LIVE BACTERIAL VACCINES FOR VIRAL INFECTION PROPHYLAXIS OR TREATMENT

 #210
20070286866
2007-12-13

Compositions for reducing bacterial carriage and CNS invasion and methods of using same

 #211
20070275014
2007-11-29

Influenza antigens, vaccine compositions, and related methods

 #212
20070231348
2007-10-04

High titer recombinant influenza viruses for vaccines

 #213
20070190163
2007-08-16

Technology for preparation of macromolecular microspheres

 #214
20070074300
2007-03-29

Sialidase inhibitors for the treatment of cardiovascular disease

 #215
20060286637
2006-12-21

Production of sialylated -glycans in lower eukaryotes

 #216
20060229247
2006-10-12

T. cruzi-derived neurotrophic agents and methods of use therefor

 #217
20060019350
2006-01-26

Recombinant negative strand RNA virus expression system and vacccines

 #218
20050221335
2005-10-06

Reporter gene

 #219
20050142116
2005-06-30

Prevention and treatment of mycoplasma-associated diseases

 #220
20050112751
2005-05-26

Class of therapeutic protein based molecules

 #221
20050032043
2005-02-10

Recombinant negative strand RNA virus expression systems and vaccines